只使用免费官方源:SEC Forms 3/4/5 结构化内部人申报,以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界,不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量;个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S(公开市场或私下交易),成交金额由股数 × 每股价格计算。
官方数据说明| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel BioFund GP Limited Partnership TenPercentOwner | 卖出(S) | 32,523 | US$6.29 | US$204,569.67 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Capital GP VI LLC TenPercentOwner | 卖出(S) | 32,523 | US$6.29 | US$204,569.67 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel GP Ltd. TenPercentOwner | 卖出(S) | 32,523 | US$6.29 | US$204,569.67 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Capital GP V LLC TenPercentOwner | 卖出(S) | 32,523 | US$6.29 | US$204,569.67 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Genesis GP LLC TenPercentOwner | 卖出(S) | 32,523 | US$6.29 | US$204,569.67 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel GP II, L.P. TenPercentOwner | 卖出(S) | 32,523 | US$6.29 | US$204,569.67 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Advisors Israel II Ltd TenPercentOwner | 卖出(S) | 40,416 | US$6.52 | US$263,512.32 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | ORBIMED ADVISORS LLC TenPercentOwner | 卖出(S) | 40,416 | US$6.52 | US$263,512.32 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel BioFund GP Limited Partnership TenPercentOwner | 卖出(S) | 40,416 | US$6.52 | US$263,512.32 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Capital GP VI LLC TenPercentOwner | 卖出(S) | 40,416 | US$6.52 | US$263,512.32 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel GP Ltd. TenPercentOwner | 卖出(S) | 40,416 | US$6.52 | US$263,512.32 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Capital GP V LLC TenPercentOwner | 卖出(S) | 40,416 | US$6.52 | US$263,512.32 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Genesis GP LLC TenPercentOwner | 卖出(S) | 40,416 | US$6.52 | US$263,512.32 | 0 | SEC |
| 2026-04-08 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel GP II, L.P. TenPercentOwner | 卖出(S) | 40,416 | US$6.52 | US$263,512.32 | 0 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Advisors Israel II Ltd TenPercentOwner | 卖出(S) | 29,319 | US$6.53 | US$191,453.07 | 34,923 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | ORBIMED ADVISORS LLC TenPercentOwner | 卖出(S) | 29,319 | US$6.53 | US$191,453.07 | 34,923 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel BioFund GP Limited Partnership TenPercentOwner | 卖出(S) | 29,319 | US$6.53 | US$191,453.07 | 34,923 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Capital GP VI LLC TenPercentOwner | 卖出(S) | 29,319 | US$6.53 | US$191,453.07 | 34,923 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel GP Ltd. TenPercentOwner | 卖出(S) | 29,319 | US$6.53 | US$191,453.07 | 34,923 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Capital GP V LLC TenPercentOwner | 卖出(S) | 29,319 | US$6.53 | US$191,453.07 | 34,923 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Genesis GP LLC TenPercentOwner | 卖出(S) | 29,319 | US$6.53 | US$191,453.07 | 34,923 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel GP II, L.P. TenPercentOwner | 卖出(S) | 29,319 | US$6.53 | US$191,453.07 | 34,923 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Advisors Israel II Ltd TenPercentOwner | 卖出(S) | 2,400 | US$6.38 | US$15,312.00 | 32,523 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | ORBIMED ADVISORS LLC TenPercentOwner | 卖出(S) | 2,400 | US$6.38 | US$15,312.00 | 32,523 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel BioFund GP Limited Partnership TenPercentOwner | 卖出(S) | 2,400 | US$6.38 | US$15,312.00 | 32,523 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Capital GP VI LLC TenPercentOwner | 卖出(S) | 2,400 | US$6.38 | US$15,312.00 | 32,523 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel GP Ltd. TenPercentOwner | 卖出(S) | 2,400 | US$6.38 | US$15,312.00 | 32,523 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Capital GP V LLC TenPercentOwner | 卖出(S) | 2,400 | US$6.38 | US$15,312.00 | 32,523 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Genesis GP LLC TenPercentOwner | 卖出(S) | 2,400 | US$6.38 | US$15,312.00 | 32,523 | SEC |
| 2026-04-07 2026-04-09 | ACET Adicet Bio, Inc. | OrbiMed Israel GP II, L.P. TenPercentOwner | 卖出(S) | 2,400 | US$6.38 | US$15,312.00 | 32,523 | SEC |
| 2026-02-20 2026-04-13 | ACET Adicet Bio, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入(P) | 74,751 | US$7.27 | US$543,439.77 | 1,182,624 | SEC |
| 2026-02-20 2026-04-13 | ACET Adicet Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入(P) | 74,751 | US$7.27 | US$543,439.77 | 1,182,624 | SEC |
| 2026-02-20 2026-04-13 | ACET Adicet Bio, Inc. | Kolchinsky Peter TenPercentOwner | 买入(P) | 74,751 | US$7.27 | US$543,439.77 | 1,182,624 | SEC |
| 2026-02-20 2026-04-13 | ACET Adicet Bio, Inc. | Shah Rajeev M. TenPercentOwner | 买入(P) | 74,751 | US$7.27 | US$543,439.77 | 1,182,624 | SEC |
| 2026-02-19 2026-04-13 | ACET Adicet Bio, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入(P) | 74,268 | US$7.21 | US$535,472.28 | 1,107,873 | SEC |
| 2026-02-19 2026-04-13 | ACET Adicet Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入(P) | 74,268 | US$7.21 | US$535,472.28 | 1,107,873 | SEC |
| 2026-02-19 2026-04-13 | ACET Adicet Bio, Inc. | Kolchinsky Peter TenPercentOwner | 买入(P) | 74,268 | US$7.21 | US$535,472.28 | 1,107,873 | SEC |
| 2026-02-19 2026-04-13 | ACET Adicet Bio, Inc. | Shah Rajeev M. TenPercentOwner | 买入(P) | 74,268 | US$7.21 | US$535,472.28 | 1,107,873 | SEC |
| 2026-02-18 2026-04-13 | ACET Adicet Bio, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入(P) | 74,577 | US$7.04 | US$525,022.08 | 1,033,605 | SEC |
| 2026-02-18 2026-04-13 | ACET Adicet Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入(P) | 74,577 | US$7.04 | US$525,022.08 | 1,033,605 | SEC |
| 2026-02-18 2026-04-13 | ACET Adicet Bio, Inc. | Kolchinsky Peter TenPercentOwner | 买入(P) | 74,577 | US$7.04 | US$525,022.08 | 1,033,605 | SEC |
| 2026-02-18 2026-04-13 | ACET Adicet Bio, Inc. | Shah Rajeev M. TenPercentOwner | 买入(P) | 74,577 | US$7.04 | US$525,022.08 | 1,033,605 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| ACET | 13,998.4465 | 51 | 44,660.0522 | 31.34% | B, Q, N |